150 related articles for article (PubMed ID: 37645026)
21. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.
Chen WX; Liu XM; Lv MM; Chen L; Zhao JH; Zhong SL; Ji MH; Hu Q; Luo Z; Wu JZ; Tang JH
PLoS One; 2014; 9(4):e95240. PubMed ID: 24740415
[TBL] [Abstract][Full Text] [Related]
22. Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p.
Hu K; Liu X; Li Y; Li Q; Xu Y; Zeng W; Zhong G; Yu C
Med Sci Monit; 2020 Aug; 26():e922253. PubMed ID: 32756532
[TBL] [Abstract][Full Text] [Related]
23. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
24. Ionizing Radiation Increases the Activity of Exosomal Secretory Pathway in MCF-7 Human Breast Cancer Cells: A Possible Way to Communicate Resistance against Radiotherapy.
Jabbari N; Nawaz M; Rezaie J
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349735
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
[TBL] [Abstract][Full Text] [Related]
26. Taxol‑resistant breast cancer cell‑derived exosome‑delivered miR‑187‑5p regulates the growth of breast cancer cells via ABCD2 and Wnt/β‑catenin signaling.
Wu T; Zhu D; Wu X; Zhang N; Zhang Q
Oncol Lett; 2023 Mar; 25(3):119. PubMed ID: 36844629
[TBL] [Abstract][Full Text] [Related]
27. Anticancer effect of rapamycin on MCF-7 via downregulation of VEGF expression.
Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
In Vitro Cell Dev Biol Anim; 2016 Jan; 52(1):45-8. PubMed ID: 26427711
[TBL] [Abstract][Full Text] [Related]
28. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death.
Choi HJ; Lui A; Ogony J; Jan R; Sims PJ; Lewis-Wambi J
Breast Cancer Res; 2015 Jan; 17(1):6. PubMed ID: 25588716
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
30. Exosome miR-134-5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1.
Yang C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
J Obstet Gynaecol Res; 2021 Nov; 47(11):4037-4048. PubMed ID: 34378285
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.
Sokolosky M; Chappell WH; Stadelman K; Abrams SL; Davis NM; Steelman LS; McCubrey JA
Cell Cycle; 2014; 13(5):820-33. PubMed ID: 24407515
[TBL] [Abstract][Full Text] [Related]
32. Exosome-mediated breast cancer chemoresistance via miR-155 transfer.
Santos JC; Lima NDS; Sarian LO; Matheu A; Ribeiro ML; Derchain SFM
Sci Rep; 2018 Jan; 8(1):829. PubMed ID: 29339789
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway.
Li Z; Qian J; Li J; Zhu C
Exp Ther Med; 2019 Jul; 18(1):435-442. PubMed ID: 31281438
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
35. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
[TBL] [Abstract][Full Text] [Related]
36. Exosome-Mediated Transfer of miR-3613-5p Enhances Doxorubicin Resistance by Suppression of PTEN Expression in Breast Cancer Cells.
Luo L; Zhang X; Rousuli Y; Aini A
J Oncol; 2022; 2022():9494910. PubMed ID: 36276272
[TBL] [Abstract][Full Text] [Related]
37. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.
Jiang L; Zhang Y; Guo L; Liu C; Wang P; Ren W
BMC Cancer; 2021 Dec; 21(1):1290. PubMed ID: 34856955
[TBL] [Abstract][Full Text] [Related]
38. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
Herman ME; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
[TBL] [Abstract][Full Text] [Related]
39. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
[TBL] [Abstract][Full Text] [Related]
40. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
